Litcius/Paper detail

In vitro efficacy of imipenem-relebactam and cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae

Lucas Tselepis, Gareth W. Langley, Ali F. Aboklaish, Emma Widlake, Dana E. Jackson, Timothy R. Walsh, Chris Schofield, Jürgen Brem, Jonathan M. Tyrrell

2020International Journal of Antimicrobial Agents52 citationsDOI

Topics & Concepts

CefepimeKlebsiella pneumoniaeMicrobiologyEnterobacteriaceaeImipenemBiologyTazobactamBeta-Lactamase InhibitorsAvibactamAntibiotic resistanceAntibioticsEscherichia coliBiochemistryGeneAntibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyInfections and bacterial resistance
In vitro efficacy of imipenem-relebactam and cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae | Litcius